October 2022 "We describe production of the human A2A adenosine receptor (A2AAR), a class A G protein-coupled receptor (GPCR) for 19F-NMR and single-molecule fluorescence (SMF) spectroscopy.

Characterization of a new WHIM syndrome mutant reveals mechanistic differences in regulation of the chemokine receptor gain-of-function mutations that lead to C-terminal truncations, frame shifts and point mutations in the chemokine receptor Interestingly, there were also significant differences in receptor degradation, with S339fs5 having a

for 19 F-NMR and single-molecule fluorescence spectroscopy "We describe production of the human A2A adenosine receptor (A2AAR), a class A G protein-coupled receptor (GPCR) for 19F-NMR and single-molecule fluorescence

October 2022 "The role of different G protein-coupled receptors (GPCRs) in the cardiovascular system In the former, stimulation of Gs-coupled receptors leads to increases in contractility, whereas stimulation of Gq-coupled receptors modulates cellular survival and hypertrophic responses. associated signaling machinery are localized in these cells with an emphasis on nuclear membrane-localized receptors

October 2022 "Biased G protein-coupled receptor (GPCR) ligands, which preferentially activate G protein

September 2022 "GPCRs are the most potential targets for drug discovery, however, their role in oncology is underappreciated and GPCR-based anti-cancer drug is not fully investigated. Herein, we identified GPR108, a GPCR protein described in innate immune system, is a potential therapeutic target of cancer. Depletion of GPR108 dramatically inhibited the survival of various cancers. Notably, TNFα activation of NF-κB was totally impaired after GPR108 knockout. We identified gambogic acid (GA), a natural prenylated xanthone, selectively targeting GPR108. Importantly, GA engaged with GPR108 and promoted its degradation, knockout of GPR108 remarkably blocked GA inhibition of NF-κB signaling. Furthermore, in vitro and in vivo assays demonstrated that GA was dependent on GPR108 to exert anti-cancer activity. Overall, our findings supported GPR108 as a promising therapeutic target of cancer, and provided a small molecule inhibitor GA directly and selectively targeting GPR108 for cancer therapy." Read more at the source #DrGPCR #GPCR #IndustryNews

Angiotensin 1-7 (Ang-1-7), an endogenous peptide, acts at the G protein coupled MAS1 receptors (MASR)

current understanding on how endogenous PTHrP transduces signals through its cognate G-protein coupled receptor (GPCR), the PTH type 1 receptor (PTHR), is largely derived from studies done with its N-terminal fragment demonstrate using various fluorescence imaging approaches at the single cell level to measure kinetics of (i) receptor activation, (ii) receptor signaling via Gs and Gq, and (iii) receptor internalization and recycling

Matthew T Eddy and his team's research on A2A adenosine receptor activation by G protein and mutations GPCR Activation and Signaling DANGER Signals Activate G -Protein Receptor Kinases Suppressing Neutrophil receptor activation by a G protein and constitutively activating mutations Distinct activation mechanisms of β-arrestin-1 revealed by 19F NMR spectroscopy Role of protease activated receptor 4 (PAR4) in mouse scaffolds-synthesis, biological activity, and structural evaluation Flavonoids as G Protein-coupled Receptors

2022 GPCRs steer G i and G s selectivity via TM5-TM6 switches as revealed by structures of serotonin receptors hydroxytryptamine, 5-HT) is an important neurotransmitter that activates 12 different G protein-coupled receptors Here, we report the structures of the serotonin receptors 5-HT4, 5-HT6, and 5-HT7 with Gs, and 5-HT4 structures reveal that transmembrane helices TM5 and TM6 alternate lengths as a macro-switch to determine receptor's selectivity or promiscuity by class A GPCRs and extend the basis of ligand recognition at serotonin receptors

neurons The activity of striatal medium-spiny projection neurons is regulated by D1 and D2 dopamine receptors The D1 receptor (D1R) is a Gαs/olf-coupled GPCR which activates a cAMP/PKA/DARPP-32 signalling cascade

Mechanistic Understanding of the Palmitoylation of Go Protein in the Allosteric Regulation of Adhesion Receptor GPR97 "Adhesion G-protein-coupled receptors (aGPCRs)-a major family of GPCRs-play critical roles in The orphan receptor GPR97, activated by glucocorticoid stress hormones, is a prototypical aGPCR.

September 2022 "GPCR signaling and function depend on their associated proteins and subcellular locations. Besides G-proteins and β-arrestins, 14-3-3 proteins participate in GPCR trafficking and signaling, and they connect a large number of diverse proteins to form signaling networks. Multiple 14-3-3 isoforms exist, and a GPCR can differentially interact with different 14-3-3 isoforms in response to agonist treatment. We found that some agonist-induced GPCR/14-3-3 signal intensities can rapidly decrease. We confirmed that this phenomenon of rapidly decreasing agonist-induced GPCR/14-3-3 signal intensity could also be paralleled with GPCR/β-arrestin-2 signals, indicating diminished levels of GPCR/signal adaptor complexes during endocytosis. The temporal signals could implicate either GPCR/14-3-3 complex dissociation or the complex undergoing a degradation process. Furthermore, we found that certain GPCR ligands can regulate GPCR/14-3-3 signals temporally, suggesting a new approach for GPCR drug development by modulating GPCR/14-3-3 signals temporally." Read more at the source #DrGPCR #GPCR #IndustryNews

G protein-coupled receptors (GPCRs) are integral membrane proteins crucial for sensing extracellular These receptors initiate intracellular signaling cascades upon activation, ultimately regulating a myriad Gq/11, and G12/13, which orchestrate downstream signaling events, including the modulation of cyclic adenosine Gilman, A.G., G proteins: transducers of receptor-generated signals.  Zhao, P., et al., Activation of the GLP-1 receptor by a non-peptidic agonist. 

GPCR Binders, Drugs, and more Inhibiting a promiscuous GPCR: iterative discovery of bitter taste receptor Sodium is a negative allosteric regulator of the ghrelin receptor. GPCRs in Cardiology, Endocrinology, and Taste Novel roles for G protein-coupled receptor kinases in cardiac Transcriptomic profiling of sex-specific olfactory neurons reveals subset-specific receptor expression receptor revealed by single-molecule FRET.

CNVs is located on chromosome 4q13.1 in the region of the gene encoding for adhesion G protein-coupled receptor

steered molecular dynamics in uncovering the dissociation kinetics of ligands targeting G-protein-coupled receptors predict the absolute residence times of the antagonist ZMA241385 and agonist NECA that target the A2A adenosine receptor of the G-protein-coupled receptor (GPCR) protein family. thermodynamics of ligand binding in terms of ligand binding energies and the per-residue contribution of the receptor

In 2008 (and for the first time in the clinic), the therapeutic benefits of the β-adrenergic receptor

October 2022 "G protein-coupled receptors (GPCRs) play critical roles in human physiology and are one allosteric sites and significantly enhanced our understanding of how allosteric ligands interact with receptors structures in complex with small-molecule allosteric ligands in terms of the location of allosteric pockets, receptor-ligand

via enhancing NLRP3 inflammasome activation in macrophages "The putative medium-chain free fatty acid receptor GPR84 is a G protein-coupled receptor primarily expressed in myeloid cells that constitute the innate

Constitutive, Basal, and β-Alanine-Mediated Activation of the Human Mas-Related G Protein-Coupled Receptor Induces Release of the Inflammatory Cytokine IL-6 and Is Dependent on NF-κB Signaling G protein-coupled receptors Members of the Mas-related G protein coupled receptors (MRGPRs), a subfamily of GPCRs, are largely expressed However, involvement of the human Mas-related G-protein coupled receptor D (MRGPRD) in the regulation

transcriptomics and peptidomics of central nervous system identify neuropeptides and their G protein-coupled receptors Neuropeptides and their specific receptors (primarily G protein-coupled receptors, GPCRs) regulate multiple

Currently, attention was mainly paid to biased signaling modulators targeting G protein-coupled receptors The biased signaling modulation of non-GPCR receptors has yet to be exploited. Toll-like receptor 4 (TLR4) is one such non-GPCR receptor, which involves MyD88-dependent and TRIF-dependent Small molecules biasedly modulating the TLR4 signaling axis not only provide probes to fine-tune receptor modulators of TLR4 would provide insight for the future development of biased modulators for other non-GPCR receptors

Recurrent high-impact mutations at cognate structural positions in class A G protein-coupled receptors expressed in tumors G protein-coupled receptors (GPCRs) are the largest family of human proteins. Because there are many more GPCRs than effectors, mutations in different receptors could perturb signaling but rather that cognate mutations with similar effects on GPCR function are distributed across many receptors We also discovered that no single receptor drives this pattern, but rather multiple receptors contain

their research on Functional consequences of spatial, temporal and ligand bias of G protein-coupled receptors Fluorescent Probes and Applications in Single-Molecule Microscopy of Wild-Type Receptors Dr. Inverse Regulation of C-C Chemokine Receptor 3 Oligomerization by Downstream Proteins Indicates Biased Fluorescent Probes and Applications in Single-Molecule Microscopy of Wild-Type Receptors Structural Insights into GPCR Function Vibrational Energy Landscapes and Energy Flow in GPCRs Allosterism in the adenosine

it contributes to pathophysiology, which is likely due to complex interactions among neuropeptides, receptor

Adhesion GPCRs Adhesion G Protein-Coupled Receptor Gpr126 (Adgrg6) Expression Profiling in Diseased Mouse 2 Inverse Agonists Development of Putative Bivalent Dicovalent Ligands for the Adenosine A1 Receptor in intestinal stem cells to exacerbate colitis The EBI2 receptor is coexpressed with CCR5 in CD4+ T Molecular Insights into GPCR Function Bilayer lipids modulate ligand binding to atypical chemokine receptor  3 Industry News New cannabinoid CB1 receptor antagonists disclosed in Inversago patent Orion Biotechnology

This communication involves the ligand-mediated control of cell surface receptors that then direct their has been placed on the ability of these therapeutics to modulate diseases by acting at cell surface receptors past decade, however, attention has focused upon how stable multiprotein GPCR superstructures, termed receptorsomes The ability of these receptorsomes (often in the absence of typical cell surface ligands) to control